Categories: Health Care

Optimal’s enabling technology for digitalisation on show at APACT

New Delhi, September 04, 2022: Optimal Industrial Technologies will be showcasing its solutions for Process Analytical Technologies (PAT) and digitalisation at the Advances in Process Analytics and Control Technologies (APACT) ’22 forum in Chester. From 14th-16th September, event attendees will be able to interact with the company’s experts to learn how to drive their digital transformation strategies forward with the leading PAT knowledge management software, synTQ.

APACT offers an open forum to discuss the latest and most promising advances in process analytics, predictive modelling and control technologies that can help achieve manufacturing excellence in a number of sectors. Data-driven solutions, such as PAT, will be key topics for discussion during the event, as they provide an empirical tool to evaluate processes and determine how to optimise them.

Thanks to its extensive expertise in this field, Optimal will contribute to the conversation by showcasing how a PAT framework that leverages synTQ can drive substantial improvements in productivity, efficiency, sustainability and product quality. The platform, which is currently used by over 60% of global pharmaceutical manufacturing majors, provides a comprehensive and intuitive interface to monitor and control machines as well as processes while also supporting fully automated operations.

Companies that implement this software can therefore advance their activities and digitalisation strategies, in line with smart manufacturing principles. Ultimately, PAT and synTQ can future proof existing facilities and assets to improve business competitiveness.

Martin Gadsby, VP at Optimal, comments: “As data-driven manufacturing becomes the norm, companies need key tools to generate, analyse and store an ever-increasing volume of data as well as act upon the intelligence generated. Industry-leading innovators, such as the top pharmaceutical producers, recognise the power and benefits that a synTQ-supported digitalisation strategy brings to their businesses. Moreover, as their customers’ expectations evolve, these manufacturers are enjoying unique competitive advantages in the marketplace, as they can quickly deliver high-quality products at lower costs. We invite anyone interested in knowing more about PAT and synTQ to talk to our experts at APACT 2022.”

Visit Optimal Industrial Technologies’ booth at APACT ’22 from 14th-16th September 2022 at the Crowne Plaza Hotel, Chester, UK: https://apact.co.uk/

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

10 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

1 day ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

5 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

6 days ago